CAPTRUST Financial Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-108	Closed	-$3K	–	4581
2022 Q2	$3K	Sell	108 -153	-59%	-$4.48K	﹤0.01%	4386
2022 Q1	$9K	Sell	261 -845	-76%	-$25.3K	﹤0.01%	3878
2021 Q4	$32K	Buy	1,106 +144	+15%	+$4.46K	﹤0.01%	2994
2021 Q3	$25K	Buy	962 +96	+11%	+$2.82K	﹤0.01%	3028
2021 Q2	$30K	Sell	866 -18	-2%	-$703	﹤0.01%	2847
2021 Q1	$36K	Buy	884 +619	+234%	+$28.5K	﹤0.01%	2649
2020 Q4	$11K	Buy	265 +15	+6%	+$740	﹤0.01%	2540
2020 Q3	$14K	Hold	250	–	–	﹤0.01%	2155
2020 Q2	$18K	Buy	+250	New	+$17.1K	﹤0.01%	1993
2019 Q4	–	Sell	-805	Closed	-$39K	–	1948
2019 Q3	$39K	Buy	805 +6	+0.8%	+$313	﹤0.01%	1078
2019 Q2	$42K	Buy	+799	New	+$45.9K	﹤0.01%	1043

Other funds holding GBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CAPTRUST Financial Advisors's GBT Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 108 shares — an estimated $3K sold.

CAPTRUST Financial Advisors first reported a position in GBT in Q2 2019 and held it in 11 quarters. The position peaked at $42K in Q2 2019. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 108 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $3K.
CAPTRUST Financial Advisors first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and held it in 11 quarters.
CAPTRUST Financial Advisors's Global Blood Therapeutics, Inc. position peaked at $42K in Q2 2019.
247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.